Impax Laboratories, Inc. Issues Voluntary, Nationwide Recall for One Lot of Lamotrigine Orally Disintegrating Tablet 200 mg Due to the Potential for 100 mg Blister Cards being Packaged in 200 mg Cont

Go back to Impax Laboratories, Inc. Issues Voluntary, Nationwide Recall for One Lot of Lamotrigine Orally Disintegrating Tablet 200 mg Due to the Potential for 100 mg Blister Cards being Packaged in 200 mg Cont

Impax Laboratories (IPXL) Issues Update on Generic Adrenaclick Auto-Injector Amid EpiPen Headlines

August 30, 2016 8:03 AM EDT

Impax Laboratories, Inc. (Nasdaq: IPXL) provided an update and additional information to patients, physicians and customers on its epinephrine... More